Want to learn more? Let us know how we can reach you.

By submitting this contact form, you are agreeing to the terms of our privacy policy. We value your information security and protect your privacy.

If you are a patient or a caregiver and want to learn more about Tablo, click here.

First Name*

Last Name*

Email Address*

Phone Number

Address 1

Address 2

Zip Code (US Only*)

State (US Only*)

Country*

Job Role*

Institution

Where are you interested in using Tablo?*

Description (How can we help?)

Please email me about Tablo, Outset Medical, clinical studies, relevant information, and events.*

Contact

For technical product support: [email protected]

For order-related questions: [email protected]

For press inquiries:
[email protected]

For help with Tablo^®, please call:

(844) MYTABLO
(844) 698-2256

1791-v1

DISCLAIMERS:

The Tablo^® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.

2214-v1

Tablo

Patients

Healthcare providers